UK grants world-first approval to Covid-19 pill molnupiravir
Molnupiravir is the first oral antiviral medication to be approved for the treatment of Covid-19.
ByUK News
Inside the MS mega-trial: inspired by cancer, supported by patients
The UK MS Society discusses how it plans to research treatments for progressive MS.
By
Common asthma drug speeds up Covid-19 recovery at home, study finds
Oxford University researchers have found that a cheap asthma drug can help speed up recovery for people at home with…
By
MDIC report explores boosting patient engagement in clinical trials
The US Medical Device Innovation Consortium (MDIC) has published a report on how to improve medical device clinical trials by…
By
MHRA pilot aims to boost patient involvement in clinical research
In a bid to put patient involvement at the heart of drug development and clinical trials, the Medicines and Healthcare…
By
GSK doses first patient with long-acting injection in Phase III asthma study
The first patient has been injected with GSK3511294 (GSK’294) as part of GlaxoSmithKline’s (GSK) SWIFT-2 Phase III trial for severe…
By
GSK to expand clinical trial manufacturing capacity at CGT Catapult site in UK
GlaxoSmithKline (GSK) will expand its presence at the UK Cell and Gene Therapy (CGT) Catapult’s Stevenage facility to carry out…
By
DemeRx and Atai get MHRA nod to start trial of ibogaine for opioid use disorder
A joint venture between DemeRx and Atai Life Sciences has been cleared by the UK Medicines and Healthcare products Regulatory…
By